.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Central Government recently announced a final extension for the CGHS empanelment deadline until April 30, 2026. Consequently, private hospitals must complete all digital formalities to avoid losing their empanelled status. This decision follows an office memorandum issued by the Director of CGHS, Dr. Satheesh Y H. Therefore, facilities now have one last window to sign the necessary Memorandum of Agreement (MoA). Previously, the government set March 31 as the cut-off date for compliance. However, many hospitals reported significant technical hurdles on the new HEM 2.0 portal. This digital platform aims to streamline applications and enhance transparency by moving all approvals online. Since these glitches slowed down the transition, authorities decided to provide more time for submission.
Non-compliance with the new timeline will lead to immediate de-empanelment starting May 1, 2026. As a result, hospitals will become ineligible to treat beneficiaries or raise payment claims. If a facility loses its status, it must submit an entirely fresh application to re-enter the scheme. Thus, meeting the CGHS empanelment deadline is crucial for maintaining hospital cash flows and patient access. Administrators often highlight the financial stress caused by delayed reimbursements. Currently, settlements can take up to 90 days, though ground feedback suggests longer delays. Furthermore, while the government revised rates in October 2025, many feel these do not fully reflect rising costs. Nevertheless, the government insists that timely digital compliance will eventually speed up the payment process for all providers.
Q1: What happens if a hospital misses the CGHS empanelment deadline?
Hospitals that do not comply by April 30, 2026, will be de-empanelled starting May 1. They will no longer be eligible to provide cashless treatment to beneficiaries or raise claims for reimbursement.
Q2: Why did the government extend the deadline to April 30?
The extension was granted because many healthcare organizations faced technical difficulties and operational hurdles while using the new HEM 2.0 digital portal.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Centre sets April 30, 2026, as the final CGHS empanelment deadline for private hospitals. Non-compliance results in de-empanelment from May 1....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
